Marksans Pharma Ltd - Artha Sootra

Overview (04 Nov 2026)

Marksans Pharma Ltd

MARKSANS

INE750C01026

Pharmaceuticals

-13.95

Prev. Close

Previous Close

315.1

Current Close

301.15

Current High

326.95

Current Low

297.4

52 Week High

350.75

52 Week Low

156

Resistance 1

319.60

Resistance 2

338.05

Support 1

290.05

Support 2

260.50

Std Deviation

5.14%

DMA 200

241.41

DMA 50

320.34

DMA 20

307.30

Fundamentals and Ratios

Standalone

Trailing EPS

6.64

Forwad EPS

7.25

Trailing P/E

45.35

Forward P/E

41.52

PEG Ratio

Mkt. Cap (Cr)

Market Cap (Cr)

13647.03

Total Debt(Cr)

Tot. Debt(Cr)

NA

Reserve (Cr)

NA

Book Value

NA

P/BV Ratio

NA

ROCE(%)

N/A

ROE

N/A

Financial Result

Standalone

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	313.8	321.19	361.57	339.73	320.44	1341.48
Other Income	57.24	17.47	27.48	15.86	58.19	103.53
Total Income	371.05	338.66	389.05	355.59	378.63	1445.01
Interest	0.34	0.34	0.35	0.36	0.32	1.33
Expenditure	-270.83	-248.20	-264.69	-273.47	-257.14	-1053.47
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-9.05	-8.78	-8.76	-8.83	-8.46	-34.23
PBT	100.21	90.46	124.36	82.12	121.49	391.54
Tax	-14.67	-21.42	-32.44	-21.20	-21.69	-90.85
Equity	45.32	45.32	45.32	45.32	0.00	45.32
OPM	27.01	26.71	31.97	23.09	37.91	27.10
Net Profit	85.54	69.04	91.92	60.91	99.81	300.7
NPM	23.05	20.39	23.63	17.13	31.15	20.81
EPS	1.89	1.52	2.03	1.34	2.2	6.64

Consolidated

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	940.17	840.8	856.11	754.43	720.41	2950.94
Other Income	18.15	25.40	35.17	20.14	21.57	82.53
Total Income	958.32	866.20	891.29	774.57	741.98	3033.47
Interest	6.83	7.00	6.31	5.94	5.82	24.13
Expenditure	-764.82	-659.63	-691.29	-623.95	-608.65	-2472.92
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-32.11	-24.86	-24.29	-24.33	-26.92	-98.63
PBT	193.50	206.57	200.00	150.62	133.33	560.56
Tax	-49.98	-47.16	-50.97	-36.93	-34.20	-140.49
Equity	45.32	45.32	45.32	0.00	0.00	45.32
OPM	20.19	23.85	22.44	19.45	17.97	18.48
Net Profit	143.53	159.41	149.03	113.69	99.14	420.06
NPM	14.98	18.4	16.72	14.68	13.36	13.85
EPS	3.12	3.47	3.27	2.5	2.17	9.22

Annual Reports

Corporate Action

Quarterly Result

Dividend

Year	Dividend Type	Amount	Remark	Ex Date
2026	Final Dividend	0.90	Final Dividend - Rs. - 0.9000	20 Aug 2026
2025	Final Dividend	0.80	Final Dividend - Rs. - 0.8000	01 Aug 2025
2024	Final Dividend	0.60	Final Dividend - Rs. - 0.6000	17 Sep 2024
2023	Final Dividend	0.50	Final Dividend - Rs. - 0.5000	07 Jun 2023
2022	Final Dividend	0.25	Final Dividend - Rs. - 0.2500	19 Aug 2022
2021	Final Dividend	0.25	Final Dividend - Rs. - 0.2500	15 Sep 2021
2020	Final Dividend	0.10	Final Dividend - Rs. - 0.1000	22 Sep 2020
2019	Final Dividend	0.05	Final Dividend - Rs. - 0.0500	19 Sep 2019
2018	Final Dividend	0.05	Dividend - Rs. - 0.0500	19 Sep 2018
2017	Final Dividend	0.05	Dividend - Rs. - 0.0500	19 Sep 2017
2016	Final Dividend	0.12	Dividend - Rs. - 0.1200	22 Sep 2016
2015	Final Dividend	0.12	Dividend - Rs. - 0.1200	23 Sep 2015
2014	Final Dividend	0.10	Dividend - Rs. - 0.1000	18 Sep 2014

Bonus

Split

Mutual Fund Holddings

Sector peers

Sector: Pharmaceuticals

Company

Current Close

P/E Ratio

1773.4

130.40

10037.5

90.60

4738.5

83.32

2323.8

120.09

1188.1

38.84

1374

413.86

1402

42.73

2537.9

45.48

1705

36.07

2008.6

16.42

1